Literature DB >> 11727788

Repeated administration of a mild acute toxic dose of di-n-butyltin dichloride at intervals of 3 weeks induces severe lesions in pancreas and liver of rats.

J Merkord1, H Weber, G Kröning, G Hennighausen.   

Abstract

Di-n-butyltin dichloride (DBTC) induced thymus atrophy, bile duct lesions, pancreatitis, and liver lesions in rats. Depending on dose [6 and 8 mg/kg intravenous (i.v.) DBTC] and time (1-24 weeks), the lesions in pancreas developed to a pancreatic fibrosis and the lesions in liver to liver cirrhosis. A single i.v. administration of 4 mg/kg DBTC induces a mild interstitial pancreatitis after 2-4 days followed by a restitutio ad integrum after 21-28 days. In the present study, the lesions of biliopancreatic duct, pancreas, and liver of rats after repeated administration of 4 mg/kg DBTC i.v. at intervals of 3 weeks have been investigated. The histopathological changes of pancreas and liver were examined by light microscopy 1,4, and 7 days and 2,3,4,6,9, and 12 weeks after administration of DBTC. Furthermore, pathobiochemical parameters of pancreatitis (amylase and lipase activity in serum), liver lesions (alkaline phosphatase activity and bilirubin in serum), and of fibrosis (hyaluronic acid in serum) were studied. Repeated administration of rats with DBTC (4 mg/kg i.v.) at intervals of 3 weeks induced an acute interstitial pancreatitis and after 9-12 weeks, a pancreatic fibrosis and liver lesions (intrahepatic bile duct hyperplasia, inflammation in periportal tract, and necrosis). In serum, elevated levels of alkaline phosphatase, bilirubin, and hyaluronic acid were found. This study demonstrates that the organotin compound induces toxic effects on pancreas and liver of rats by repeated administration of lower doses at long intervals. The risk of exposure to organotin at long intervals should be considered.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11727788     DOI: 10.1191/096032701682692964

Source DB:  PubMed          Journal:  Hum Exp Toxicol        ISSN: 0960-3271            Impact factor:   2.903


  5 in total

Review 1.  Animal Models: Challenges and Opportunities to Determine Optimal Experimental Models of Pancreatitis and Pancreatic Cancer.

Authors:  Jami L Saloman; Kathryn M Albers; Zobeida Cruz-Monserrate; Brian M Davis; Mouad Edderkaoui; Guido Eibl; Ariel Y Epouhe; Jeremy Y Gedeon; Fred S Gorelick; Paul J Grippo; Guy E Groblewski; Sohail Z Husain; Keane K Y Lai; Stephen J Pandol; Aliye Uc; Li Wen; David C Whitcomb
Journal:  Pancreas       Date:  2019-07       Impact factor: 3.327

2.  Pathophysiology of chronic pancreatitis induced by dibutyltin dichloride joint ethanol in mice.

Authors:  Hong Zhang; Bin Liu; Xiao-Fan Xu; Ting-Ting Jiang; Xiao-Qin Zhang; Ying-Li Shi; Yu Chen; Fang Liu; Jie Gu; Lin-Jia Zhu; Nan Wu
Journal:  World J Gastroenterol       Date:  2016-03-14       Impact factor: 5.742

3.  Animal models for investigating chronic pancreatitis.

Authors:  Alexander A Aghdassi; Julia Mayerle; Sandra Christochowitz; Frank U Weiss; Matthias Sendler; Markus M Lerch
Journal:  Fibrogenesis Tissue Repair       Date:  2011-12-01

4.  Dibutyltin disrupts glucocorticoid receptor function and impairs glucocorticoid-induced suppression of cytokine production.

Authors:  Christel Gumy; Charlie Chandsawangbhuwana; Anna A Dzyakanchuk; Denise V Kratschmar; Michael E Baker; Alex Odermatt
Journal:  PLoS One       Date:  2008-10-28       Impact factor: 3.240

5.  Influence of daily oral prophylactic selenium treatment on the dibutyltin dichloride (DBTC)-induced pancreatitis in rats.

Authors:  J Merkord; N Görl; M Lemke; A Berg; H Weber; R Ramer; G Hennighausen
Journal:  EXCLI J       Date:  2017-02-16       Impact factor: 4.068

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.